Business Description
Advagene Biopharma Co Ltd
ISIN : TW0006709009
Share Class Description:
ROCO:6709: Ordinary SharesTotal Employee Number:
12Description
Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based biotechnology company. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray seasonal flu vaccine, nasal spray COVID-19 vaccine, Immunotherapy for COVID-19, Respiratory Allergy Immunotherapy - Allergic Rhinitis and Asthma ,and other vaccines.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 24.85 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.08 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.9 | |||||
3-Year EPS without NRI Growth Rate | 21.8 | |||||
3-Year FCF Growth Rate | 23 | |||||
3-Year Book Growth Rate | -1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.7 | |||||
9-Day RSI | 39.58 | |||||
14-Day RSI | 42.38 | |||||
3-1 Month Momentum % | -3.85 | |||||
6-1 Month Momentum % | -3.75 | |||||
12-1 Month Momentum % | 20.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.69 | |||||
Quick Ratio | 13.69 | |||||
Cash Ratio | 11.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6 | |||||
Shareholder Yield % | 0.08 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -36.57 | |||||
ROA % | -34.37 | |||||
ROIC % | -291.14 | |||||
3-Year ROIIC % | -576.68 | |||||
ROC (Joel Greenblatt) % | -285.46 | |||||
ROCE % | -35.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 9.53 | |||||
Price-to-Tangible-Book | 9.55 | |||||
EV-to-EBIT | -23.1 | |||||
EV-to-EBITDA | -23.88 | |||||
EV-to-FCF | -24.77 | |||||
| Price-to-Net-Current-Asset-Value | 10.02 | |||||
| Price-to-Net-Cash | 12.05 | |||||
Earnings Yield (Greenblatt) % | -4.32 | |||||
FCF Yield % | -3.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advagene Biopharma Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | |||
| EPS (TTM) (NT$) | -1.147 | ||
| Beta | 0.0663 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.04 | ||
| Volatility % | 60.64 | ||
| 14-Day RSI | 42.38 | ||
| 14-Day ATR (NT$) | 0.72874 | ||
| 20-Day SMA (NT$) | 24.8925 | ||
| 12-1 Month Momentum % | 20.78 | ||
| 52-Week Range (NT$) | 19.454699 - 40.800136 | ||
| Shares Outstanding (Mil) | 69.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advagene Biopharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advagene Biopharma Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Advagene Biopharma Co Ltd Frequently Asked Questions
What is Advagene Biopharma Co Ltd(ROCO:6709)'s stock price today?
The current price of ROCO:6709 is NT$24.35. The 52 week high of ROCO:6709 is NT$40.80 and 52 week low is NT$19.45.
When is next earnings date of Advagene Biopharma Co Ltd(ROCO:6709)?
The next earnings date of Advagene Biopharma Co Ltd(ROCO:6709) is .
Does Advagene Biopharma Co Ltd(ROCO:6709) pay dividends? If so, how much?
Advagene Biopharma Co Ltd(ROCO:6709) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Advagene Biopharma Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers